Drug Interactions and Side Effects of Lithium Carbonate and Ziprasidone Hcl and Divalproex Sodium and Lorazepam and Losartan Potassium and Ibuprofen and Furosemide and Diphenhydramine Hcl and Acetaminophen and Ipratropium Bromide
>>> Check my drugs now
| Report ID | Date of report | Patient age | Patient gender |
| 81053 | Mar, 17, 2006 | 47 | Male |
List of drugs the patient takes:
| Drug | Ingredient(s) |
Lithium Carbonate | lithium carbonate |
Ziprasidone Hcl | ziprasidone hydrochloride |
Divalproex Sodium | divalproex sodium |
Lorazepam | lorazepam |
Losartan Potassium | losartan potassium |
Ibuprofen | ibuprofen |
Furosemide | furosemide |
Diphenhydramine Hcl | diphenhydramine hydrochloride |
Acetaminophen | acetaminophen |
Ipratropium Bromide | ipratropium bromide |
| Name |
Abasia |
Agitation |
Alanine Aminotransferase Increased |
Antipsychotic Drug Level Increased |
Aspartate Aminotransferase Increased |
Blood Creatine Phosphokinase Increased |
Blood Creatinine Increased |
Blood Iron Decreased |
Blood Potassium Increased |
Blood Sodium Increased |
Condition Aggravated |
Diabetes Insipidus |
Drug Ineffective |
Drug Level Below Therapeutic |
Dyspnoea |
Hyperthermia |
Hypotension |
Infection |
Loss Of Consciousness |
Mania |
Mental Status Changes |
Myoglobinuria |
Neuroleptic Malignant Syndrome |
No Therapeutic Response |
Renal Disorder |
Sepsis |
Somnolence |
Tachypnoea |
White Blood Cell Count Increased |
Results from eHealthMe : 2 report(s)Comparison with the patient:
| Name | Count (% of total reports) |
Abasia | 2 (100.00%) |
Agitation | 1 (50.00%) |
Alanine Aminotransferase Increased | 1 (50.00%) |
Antipsychotic Drug Level Increased | 1 (50.00%) |
Aspartate Aminotransferase Increased | 1 (50.00%) |
Blood Creatine Phosphokinase Increased | 1 (50.00%) |
Blood Creatinine Increased | 2 (100.00%) |
Blood Iron Decreased | 1 (50.00%) |
Blood Potassium Increased | 2 (100.00%) |
Blood Sodium Increased | 1 (50.00%) |
Condition Aggravated | 1 (50.00%) |
Diabetes Insipidus | 2 (100.00%) |
Drug Ineffective | 1 (50.00%) |
Drug Level Below Therapeutic | 1 (50.00%) |
Dyspnoea | 1 (50.00%) |
Hyperthermia | 1 (50.00%) |
Hypotension | 1 (50.00%) |
Infection | 1 (50.00%) |
Loss Of Consciousness | 2 (100.00%) |
Mania | 1 (50.00%) |
Mental Status Changes | 1 (50.00%) |
Myoglobinuria | 1 (50.00%) |
Neuroleptic Malignant Syndrome | 2 (100.00%) |
No Therapeutic Response | 1 (50.00%) |
Renal Disorder | 1 (50.00%) |
Sepsis | 2 (100.00%) |
Somnolence | 2 (100.00%) |
Tachypnoea | 2 (100.00%) |
White Blood Cell Count Increased | 1 (50.00%) |
Top 3 (total: 1. Click here to see more) co-used drugs - potential interacting drugs:
| Name | Count (% of total co-drugs) |
Flunisolide | 1 (4.76%) |
Death reported: 0
| Name | Count (% of total reports) |
Loss Of Consciousness | 2 (100.00%) |
Sepsis | 2 (100.00%) |
Diabetes Insipidus | 2 (100.00%) |
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Recent drug risk analysis reports:
|
|
Don't find what you want? We have customized services for patients, professionals, and clinics. Let us know (click here) and see whether we can help.
| |
